Article: HIV-VAC'S Dr. Gordon Skinner Discusses AIDS Vaccine Potential to Halt Rising Worldwide Death Toll.

TORONTO--(BUSINESS WIRE)--Dec. 17, 1999--

HIV-VAC, Inc., (OTCBB:HIVC) today announced that Dr. Gordon Skinner, MD (Hons), DSc, FRCOG, FRCPath, the developer of the Skinner HIV-VAC AIDS vaccine, was interviewed by WallStreetInterview.com to discuss the vaccine's potential to end the worldwide AIDS epidemic.

Dr. Skinner's interview can be heard at the Internet address: www.wallstreetinterview.com/hivc.ram

Unlike other AIDS vaccines currently under development, the Skinner HIV-VAC AIDS vaccine is based on a new and very unique approach to neutralizing the AIDS virus that has the potential to be effective with the AIDS virus' many mutant forms. This ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!